VNS Group of Institutions D Pharma : Fees, Courses, Eligibility & Admission 2025

VNS Group of Institutions D Pharma is a 2 - 3 Years program offered in multiple specializations. The eligibility criteria for the Diploma in Pharmacy degree at VNS Group of Institutions in India require candidates to have completed their 10+2 education with science subjects, including Physics, Chemistry, and Biology/Mathematics. Additionally, candidates should have obtained a minimum aggregate score of 50% in their qualifying examination. It is also necessary for candidates to have studied English as a subject in their 10+2 education. Meeting these criteria will enable aspiring students to pursue the Diploma in Pharmacy program at VNS Group of Institutions, which aims to equip them with the necessary knowledge and skills to excel in the pharmaceutical industry. The annual fee for D Pharma is INR 45,000 - 88,000. More details about eligibility criteria, fees, admission process, selection criteria, application fees, how to apply, and important dates for VNS Group of Institutions D Pharma admission are given below:

VNS Group of Institutions D Pharma fees is 45,000 INR (Yearly) and goes up to 88,000 INR (Yearly) depending on the specialization. The average fees for the D Pharma course is 66,500 INR (Yearly). VNS Group of Institutions D Pharma admission 2025 will be based on NEET, MPBSE 12th, CBSE 12th.

The eligibility criteria for the Diploma in Pharmacy degree at VNS Group of Institutions in India require candidates to have completed their 10+2 education with science subjects, including Physics, Chemistry, and Biology/Mathematics. Additionally, candidates should have obtained a minimum aggregate score of 50% in their qualifying examination. It is also necessary for candidates to have studied English as a subject in their 10+2 education. Meeting these criteria will enable aspiring students to pursue the Diploma in Pharmacy program at VNS Group of Institutions, which aims to equip them with the necessary knowledge and skills to excel in the pharmaceutical industry.